SCHOFIELD, Wis., April 14, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is providing an update to its shareholders regarding the next steps in introducing its non-prescription migraine product, LipiGesic™ M, to the national retail market.
